Back

Effects of Glutamate Delta 1 Receptor (GluD1) Deletion on the Ultrastructural Features of Corticostriatal and Thalamostriatal Synapses in Mice

Yue, L.; Dalal, K.; Dravid, S. M.; Smith, Y.; Villalba, R. M.

2026-05-28 neuroscience
10.64898/2026.05.26.727726 bioRxiv
Show abstract

The glutamate delta 1 receptor (GluD1) represents a unique subtype of ionotropic glutamate receptors that is strongly expressed in the mammalian striatum. Disruptions of the GRID1 gene, which encodes GluD1, have been associated with neuropsychiatric disorders, including schizophrenia and autism spectrum disorder; however, the role of GluD1 in the brain remains poorly understood. Previous studies in mice have demonstrated that the knockout of striatal GluD1 led to fear-conditioning deficits and depressive-like behaviors. Furthermore, these mice exhibited reduced excitatory input to the striatum due to a loss of thalamostriatal innervation, whereas corticostriatal innervation was unaffected. In this study, we examined whether changes in synapse morphology contribute to the observed functional deficits. We found that the ablation of GluD1 does not affect synaptic targeting patterns of corticostriatal and thalamostriatal terminals, using transmission electron microscopy. We further utilized three-dimensional reconstruction to obtain quantitative data on synapse ultrastructure and found no significant changes in corticostriatal and thalamostriatal synaptic components, including the presynaptic terminal volume, postsynaptic density area and morphology, and postsynaptic dendritic spine volume. These findings support a model in which GluD1 regulates input-specific circuit organization and synaptic connectivity rather than the structural morphology of individual synapses.

Matching journals

The top 14 journals account for 50% of the predicted probability mass.

1
Translational Psychiatry
219 papers in training set
Top 0.4%
12.3%
2
Scientific Reports
3102 papers in training set
Top 12%
7.1%
3
Neuroscience
88 papers in training set
Top 0.1%
4.3%
4
Molecular Brain
26 papers in training set
Top 0.1%
3.6%
5
eneuro
389 papers in training set
Top 3%
3.6%
6
Biological Psychiatry
119 papers in training set
Top 1%
2.6%
7
Neurobiology of Disease
134 papers in training set
Top 2%
2.6%
8
Molecular Psychiatry
242 papers in training set
Top 1%
2.5%
9
Neuroscience Letters
28 papers in training set
Top 0.2%
2.3%
10
Frontiers in Molecular Neuroscience
43 papers in training set
Top 0.2%
2.1%
11
Journal of Neuroscience Research
25 papers in training set
Top 0.1%
2.1%
12
Journal of Neurochemistry
50 papers in training set
Top 0.1%
2.1%
13
Frontiers in Cellular Neuroscience
79 papers in training set
Top 0.3%
1.9%
14
Molecular and Cellular Neuroscience
18 papers in training set
Top 0.1%
1.9%
50% of probability mass above
15
PLOS ONE
4510 papers in training set
Top 50%
1.9%
16
Journal of Neuroendocrinology
19 papers in training set
Top 0.2%
1.9%
17
Neuropsychopharmacology
134 papers in training set
Top 2%
1.7%
18
Frontiers in Neuroscience
223 papers in training set
Top 4%
1.7%
19
European Journal of Neuroscience
168 papers in training set
Top 0.5%
1.7%
20
eLife
5422 papers in training set
Top 42%
1.7%
21
Schizophrenia Research
29 papers in training set
Top 0.4%
1.7%
22
The Journal of Neuroscience
928 papers in training set
Top 6%
1.7%
23
Brain Sciences
52 papers in training set
Top 0.9%
1.5%
24
Molecular Neurobiology
50 papers in training set
Top 0.4%
1.5%
25
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 0.5%
1.5%
26
Frontiers in Neural Circuits
36 papers in training set
Top 0.4%
1.3%
27
Frontiers in Synaptic Neuroscience
14 papers in training set
Top 0.1%
1.2%
28
Addiction Biology
47 papers in training set
Top 0.6%
1.1%
29
Experimental Neurology
57 papers in training set
Top 1%
0.9%
30
International Journal of Molecular Sciences
453 papers in training set
Top 12%
0.9%